New ACC/AHA/HRS Guideline on Evaluating, Managing Bradycardia
A new guideline released today by the ACC, American Heart Association (AHA) and the Heart Rhythm Society (HRS) outlines the clinical presentation and approach to clinical evaluation of patients who may have bradycardia or conduction diseases.
In developing the 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients with Bradycardia and Cardiac Conduction Delay, the writing committee reviewed study data and developed recommendations addressing the selection and timing of diagnostic testing tools, as well as available treatment options such as lifestyle interventions, pharmacotherapy and external and implanted devices.
Specifically, the guideline describes the clinical significance of bradycardia with respect to mortality, symptoms (i.e., syncope and impaired functional capacity) and exacerbations of related disorders like ischemia, heart failure and provoked tachyarrhythmias. It also aims to delineate the clinical presentation and general approach to clinical evaluation of patients with overt or suspected bradycardias or conduction diseases.
The writing committee also looked at special considerations for different populations based on age, comorbidities or other relevant factors. Key to addressing special considerations well: shared decision-making between the patient and clinicians, as well as patient-centered care. “Treatment decisions are based not only on the best available evidence but also on the patient’s goals of care and preferences,” says Fred M. Kusumoto, MD, FACC, chair of the writing committee. “Patients should be referred to trusted material to aid in their understanding and awareness of the consequences and risks of any proposed action.”
Visit the Bradycardia and Cardiac Conduction Delay Guideline Hub on ACC.org for resources including a slide set, perspectives, apps and tools, and CardioSmart patient resources. The Bradycardia Guideline Hub on JACC also features tools including the central illustration.
Use promo code “MyFACC” to waive the $150 application fee! Remember: Dues to not increase when you upgrade your membership to FACC. Apply NOW
CMS Releases Final 2019 Physician Fee Schedule On Nov. 1, the Centers for Medicare and Medicaid Services (CMS) released the final 2019 Medicare Physician Fee Schedule (PFS) rule, addressing Medicare payment rates and policy provisions for physicians in 2019. Per the final ruling, physicians will see a 0.1 percent conversion factor payment increase on…
Acknowledge National Hospice and Palliative Care Month This November Join the ACC in recognizing National Hospice and Palliative Care Month this November to raise awareness about how important hospice and palliative care is to all ages. To help these patients know what to expect and better understand their health, ACC’s CardioSmart team created a palliative…
New ACC/AHA Cholesterol Guideline Allows For More Personalized Care; New Treatment Options The new 2018 ACC/AHA Guideline on the Management of Blood Cholesterol was released this morning during AHA 2018 in Chicago and simultaneously published in the Journal of the American College of Cardiology and Circulation. The new guideline updates its 2013 predecessor and provides…
Learn how to make this transition happen quickly and easily.